Eagle Asset Management Inc Intellia Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$23.16 - $32.34 $622,239 - $868,878
26,867 Added 11.07%
269,558 $8.22 Million
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $235,948 - $341,610
7,462 Added 3.17%
242,691 $7.67 Million
Q2 2023

Aug 09, 2023
BUY
$34.58 - $46.03 $2.19 Million - $2.92 Million
63,350 Added 36.86%
235,229 $9.59 Million
Q1 2023

May 08, 2023
SELL
$33.3 - $44.82 $515,683 - $694,082
-15,486 Reduced 8.27%
171,879 $6.41 Million
Q4 2022

Feb 14, 2023
SELL
$33.21 - $62.69 $255,650 - $482,587
-7,698 Reduced 3.95%
187,365 $6.54 Million
Q3 2022

Nov 07, 2022
SELL
$53.92 - $71.7 $214,008 - $284,577
-3,969 Reduced 1.99%
195,063 $10.9 Million
Q2 2022

Aug 10, 2022
SELL
$38.49 - $76.21 $1.25 Million - $2.48 Million
-32,485 Reduced 14.03%
199,032 $10.3 Million
Q1 2022

May 12, 2022
BUY
$58.27 - $118.99 $589,284 - $1.2 Million
10,113 Added 4.57%
231,517 $16.8 Million
Q4 2021

Feb 11, 2022
SELL
$100.76 - $138.36 $998,330 - $1.37 Million
-9,908 Reduced 4.28%
221,404 $26.8 Million
Q3 2021

Nov 10, 2021
SELL
$132.37 - $176.78 $4.61 Million - $6.15 Million
-34,811 Reduced 13.08%
231,312 $31 Million
Q2 2021

Aug 11, 2021
BUY
$60.88 - $161.91 $16.2 Million - $43.1 Million
266,123 New
266,123 $43.1 Million

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email